Skip to main content
. 2020 Dec 16;34(4):213–237. doi: 10.4285/kjt.20.0026

Fig. 2.

Fig. 2

The cumulative incidence rate of posttransplant diabetes mellitus in the tacrolimus (FK)-based and cyclosporine (CsA)-based groups.